MediPharm Labs Corp. (TSE:LABS – Get Free Report)’s share price hit a new 52-week low on Friday . The stock traded as low as C$0.06 and last traded at C$0.07, with a volume of 206733 shares. The stock had previously closed at C$0.07.
MediPharm Labs Price Performance
The company has a current ratio of 3.11, a quick ratio of 3.10 and a debt-to-equity ratio of 5.90. The stock’s 50-day moving average price is C$0.07 and its 200-day moving average price is C$0.07. The company has a market cap of C$26.72 million, a P/E ratio of -1.63 and a beta of 0.88.
MediPharm Labs Company Profile
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products.
Further Reading
- Five stocks we like better than MediPharm Labs
- With Risk Tolerance, One Size Does Not Fit All
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- 3 Buy-and-Hold Stocks for Long-Term Growth
- How to Effectively Use the MarketBeat Ratings Screener
- Despite Short-Term Risks Freeport McMoran Worth a Look
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
